Abstract
The Scandinavian Candesartan Acute Stroke Trial (SCAST) found no benefits of candesartan in acute stroke. In the present analysis we aim to investigate the effect of change in blood pressure during the first 2 days of stroke on the risk of early adverse events and poor outcome.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Stroke |
| Vol/bind | 43 |
| Udgave nummer | 8 |
| Sider (fra-til) | 2108-14 |
| Antal sider | 7 |
| ISSN | 0039-2499 |
| DOI | |
| Status | Udgivet - 2012 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS